PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT

This adverse event was reported 46 times

These drugs are most commonly taken by patients reporting PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT:

# Drug Count
0 PREDNISONE 25
1 RITUXIMAB 21
2 CYCLOPHOSPHAMIDE 20
3 CYCLOPHOSPHAMIDE FOR INJECTION 20
4 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 20
5 ETOPOSIDE 18
6 DOXORUBICIN 14
7 METHOTREXATE 11
8 METHOTREXATE SODIUM 11
9 AXICABTAGENE CILOLEUCEL 9
See all common drugs associated with PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT

PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AXICABTAGENE CILOLEUCEL 9 0.0009
1 BLEOMYCIN SULFATE 8 0.0008
2 VINORELBINE 5 0.0007
3 POLATUZUMAB VEDOTIN 4 0.0004
4 IFOSFAMIDE FOR INJECTION 7 0.0003
5 ETOPOSIDE 18 0.0002
6 BLINATUMOMAB 2 0.0002
7 FLUDARABINE PHOSPHATE 7 0.0002
8 DOXORUBICIN 14 0.0002
9 MESNA INJECTION 1 0.0001
See all drugs enriched for association with PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA RECURRENT